Please login to the form below

Not currently logged in
Email:
Password:

Amgen poaches J&J’s Ray Jordan for corporate affairs post

He joins on October, 1 with a strategic communications remit

Amgen has appointed Ray Jordan to fill the newly created position of senior vice president of corporate affairs.

He will join the US biotech on October, 1 from Johnson & Johnson, where he has served as communications leader with responsibility for corporate comms and public affairs since 2003.

Prior to joining J&J, Jordan was vice president of communications and information for Pfizer, where he held a range of positions over the course of 17 years.

He has also served as chair of PhRMA's public affairs section and, earlier in his career, as a reporter for a regional daily newspaper as well as holding positions with Bristol-Myers and business information company Dun & Bradstreet.

In his new role Jordan will be responsible for strategic communications across Amgen, including internal and external communications, issues management and philanthropy, and report directly to Robert Bradway, Amgen's president and CEO.

Bradway said: "We are very pleased to have Ray join Amgen. He is a strategic thinker and communicator with skills honed at two respected global health care companies.

“Ray's background in both business management and communication will serve Amgen well as we execute on our strategy to deliver results for both patients and shareholders."

12th September 2012

From: Marketing

Share

Tags

Featured jobs

Senior Brand Manager - Harlow
Competitive
Sales Manager - Media Publishing – Cheshire
25,000 to 35,000 per annum
UK Marketing Director
80,000 to 100,000 per annum
Group Account Director –Healthcare Advertising
Neg

Subscribe to our email news alerts

PMHub

Add my company
Kane & Finkel Healthcare Communications, Ltd.

Kane & Finkel (K& F) is a global healthcare brand communications firm specialising in marketing pharmaceutical, biotech, medical device, ...

Latest intelligence

Online Physician Communities
How can pharma deliver returns on increased digital investment?
Independent online professional networks work best as part of a multi-channel campaign  ...
The impact of Hollande's healthcare reforms in France
A tougher environment for pharma, with market access and regulatory challenges...
Customer-centred_multichannel_marketing_-_419x336.png
A guide to developing customer-centred, multichannel marketing
Find out how a balanced approached to multichannel marketing could benefit your brand - the customer's agenda is just as important as Pharma's and needs to be listened to in ...